ENST00000647020.1:c.-82C>A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000647020.1(HBB):c.-82C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000122 in 821,440 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000647020.1 5_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000122 AC: 1AN: 821440Hom.: 0 Cov.: 11 AF XY: 0.00 AC XY: 0AN XY: 432430
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
beta Thalassemia Pathogenic:1
- -
Beta-plus-thalassemia Pathogenic:1
- -
not specified Uncertain:1
Variant summary: HBB c.-82C>A affects a non-conserved nucleotide that is located in the untranscribed region, one nucleotide upstream to the conserved ATAAA sequence (i.e. the TATA box) therefore, it could affect gene expression. A saturation mutagenesis study reported that this variant had no significant effect on gene expression (Kircher_2019). The variant was absent in 31390 control chromosomes (gnomAD). c.-82C>A has been reported in the literature in at-least one individual with features of Beta Thalassemia (example: Lin_1992). These data indicate that the variant may be associated with disease. One submitter provided clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at